RA Capital
Status
ACTIVE
Global HQ
Boston, United States
Countries of investment
- USA
Investment stages
- Pre-Seed
- Seed
Industries
- Health Tech
- Biotechnology
- Fintech
- AI
About
RA Capital Management is a prominent Boston-based investment advisor dedicated to advancing innovation in healthcare, life sciences, and drug development. With a robust portfolio, the firm not only funds and builds companies within these sectors but also actively explores opportunities in climate and sustainability technologies. Leveraging deep industry expertise, RA Capital aims to drive transformative advancements that address pressing global challenges while delivering strong returns for its investors. Their commitment to fostering groundbreaking solutions underscores their position as a leader in the investment landscape.
RA Capital Management is a prominent Boston-based investment advisor dedicated to advancing innovation in healthcare, life sciences, and drug development. With a robust portfolio, the firm not only funds and builds companies within these sectors but also actively explores opportunities in climate and sustainability technologies. Leveraging deep industry expertise, RA Capital aims to drive transformative advancements that address pressing global challenges while delivering strong returns for its investors. Their commitment to fostering groundbreaking solutions underscores their position as a leader in the investment landscape.
Investment Thesis
RA Capital is dedicated to evidencebased investing in public and private healthcare and life science companies, focusing on drugs, medical devices, diagnostics, services, and research tools.
Manager's Experience
With extensive experience in private equity, the fund manager has built a diverse portfolio by executing over 50 deals, primarily focused on technology and healthcare sectors. Active across North America and Europe, their strategic style emphasizes a data-driven approach, targeting growth-stage investments. Notable exits include several high-profile IPOs, showcasing a commitment to generating significant returns. Their operator-first methodology ensures deep engagement with portfolio companies, fostering sustainable growth and innovation.
Team
Zach Scheiner
Stephanie Moore
Rajeev Shah
Pieter Boelhouwer
Peter Kolchinsky
Nicholas Mcgrath
Michael Saulnier
Michael Calore
Laura Stoppel
Katie Maher